Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001013762-25-004330
Filing Date
2025-03-28
Accepted
2025-03-28 19:36:47
Documents
1
Period of Report
2025-03-26

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 7921
  Complete submission text file 0001013762-25-004330.txt   10216
Mailing Address 888 BOYLSTON, SUITE 500 BOSTON MA 02199
Business Address 888 BOYLSTON, SUITE 500 BOSTON MA 02199 (617) 449-7700
M33 Growth I L.P. (Reporting) CIK: 0001718621 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39248 | Film No.: 25788323

Mailing Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703
Business Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703 562-735-3226
Oncology Institute, Inc. (Issuer) CIK: 0001799191 (see all company filings)

EIN.: 843562323 | Fiscal Year End: 1231
SIC: 8011 Services-Offices & Clinics of Doctors of Medicine
(CF Office: 08 Industrial Applications and Services)

Mailing Address 888 BOYLSTON STREET. SUITE 500 BOSTON MA 02199-8202
Business Address 888 BOYLSTON STREET. SUITE 500 BOSTON MA 02199-8202 (617) 410-4700
M33 Growth I GP LLC (Reporting) CIK: 0001894303 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39248 | Film No.: 25788322